Direct‐Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C

Medicaid prior authorization (PA) policies for treatment of hepatitis C virus (HCV) with direct‐acting antiviral (DAA) therapy are changing. We aimed to evaluate effects of changes in PA requirements on treatment uptake and to determine the factors associated with DAA treatment among Florida Medicai...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Haesuk, Song, Hyun Jin, Jiang, Xinyi, Henry, Linda, Cook, Robert L., Nelson, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850300/
https://www.ncbi.nlm.nih.gov/pubmed/33553969
http://dx.doi.org/10.1002/hep4.1634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850300/
https://www.ncbi.nlm.nih.gov/pubmed/33553969
http://dx.doi.org/10.1002/hep4.1634

Ejemplares similares